🇺🇸 FDA
Patent

US 7705031

Benzimidazoles useful as modulators of ion channels

granted A61PA61P1/00A61P1/02

Quick answer

US patent 7705031 (Benzimidazoles useful as modulators of ion channels) held by Vertex Pharmaceuticals Incorporated expires Mon Apr 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Apr 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61P, A61P1/00, A61P1/02, A61P1/04, A61P1/16